Blood cancers, Chronic leukaemia, Leukaemia
Results
Phase 2
This study looked at a targeted cancer drug called tefinostat for chronic myelomonocytic leukaemia (CMML).
This study was open for people to join between January 2017 and January 2018. These results were presented at a conference in 2018.
Recruitment start: 16 January 2017
Recruitment end: 31 January 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Steven Knapper
Cardiff University
NIHR Clinical Research Network: Cancer
Bloodwise
Last reviewed: 18 June 2020
CRUK internal database number: 12683
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
